Literature DB >> 22906655

Association of urolithiasis with systemic conditions among pediatric patients at children's hospitals.

Paul J Kokorowski1, Jonathan C Routh, Katherine C Hubert, Dionne A Graham, Caleb P Nelson.   

Abstract

PURPOSE: Urolithiasis is associated with systemic medical conditions in adults but associations have not been well studied in children. We investigated the association of urolithiasis with diabetes mellitus, hypertension and obesity among children with and without urolithiasis.
MATERIALS AND METHODS: We performed a matched case-control study using the PHIS (Pediatric Health Information System) database. ICD-9 codes identified urolithiasis cases from 2004 to 2009. Four randomly selected controls were matched by age, hospital, patient care setting and year of treatment. Diagnoses from all hospital encounters were ascertained for comorbid conditions. Univariate and multivariable conditional logistic regression was used to assess the associations of urolithiasis with diabetes mellitus, hypertension and obesity.
RESULTS: We identified 9,843 urolithiasis cases and 39,047 controls. On univariate analysis stone formers had significantly higher odds of obesity (OR 1.44, 95% CI 1.27-1.64) and hypertension (OR 2.12, 95% CI 1.88-2.40) compared to controls. The odds of type I diabetes mellitus was lower among cases compared to controls (OR 0.38, 95% CI 0.30-0.48). After adjusting for gender, race, insurance type and number of visits using logistic regression, children with urolithiasis still had higher odds of obesity (AOR 1.30, 95% CI 1.12-1.51) and hypertension (AOR 1.61, 95% CI 1.40-1.86) as well as lower odds of type I diabetes mellitus (AOR 0.32, 95% CI 0.25-0.41) compared to controls.
CONCLUSIONS: Among pediatric patients at freestanding children's hospitals, urolithiasis is associated with higher odds of obesity and hypertension and lower odds of type I diabetes mellitus. These findings may be helpful in further elucidating the etiology of pediatric urolithiasis.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22906655      PMCID: PMC4005878          DOI: 10.1016/j.juro.2012.02.019

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Medical comorbidities associated with pediatric kidney stone disease.

Authors:  Anthony J Schaeffer; Zhaoyong Feng; Bruce J Trock; Ranjiv I Mathews; Alicia M Neu; John P Gearhart; Brian R Matlaga
Journal:  Urology       Date:  2010-10-23       Impact factor: 2.649

2.  Insulin resistance and low urinary citrate excretion in calcium stone formers.

Authors:  A Cupisti; M Meola; C D'Alessandro; G Bernabini; E Pasquali; A Carpi; G Barsotti
Journal:  Biomed Pharmacother       Date:  2006-12-04       Impact factor: 6.529

3.  Body size and 24-hour urine composition.

Authors:  Eric N Taylor; Gary C Curhan
Journal:  Am J Kidney Dis       Date:  2006-12       Impact factor: 8.860

4.  Renal stone epidemiology: a 25-year study in Rochester, Minnesota.

Authors:  C M Johnson; D M Wilson; W M O'Fallon; R S Malek; L T Kurland
Journal:  Kidney Int       Date:  1979-11       Impact factor: 10.612

Review 5.  The association of nephrolithiasis with hypertension and obesity: a review.

Authors:  Sergio H Obligado; David S Goldfarb
Journal:  Am J Hypertens       Date:  2008-01-24       Impact factor: 2.689

6.  Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994.

Authors:  Bradford West; Amy Luke; Ramon A Durazo-Arvizu; Guichan Cao; David Shoham; Holly Kramer
Journal:  Am J Kidney Dis       Date:  2008-03-20       Impact factor: 8.860

7.  Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity.

Authors:  Domenico Rendina; Giuseppe Mossetti; Gianpaolo De Filippo; Domenico Benvenuto; Carmen Liliana Vivona; Alessia Imbroinise; Giorgia Zampa; Salvatore Ricchio; Pasquale Strazzullo
Journal:  Nephrol Dial Transplant       Date:  2008-10-03       Impact factor: 5.992

8.  Increased acid excretion in kidney stone formers with essential hypertension.

Authors:  Attilio Losito; Emidio Giovanni Nunzi; Carla Covarelli; Elisabetta Nunzi; Gaetano Ferrara
Journal:  Nephrol Dial Transplant       Date:  2008-08-20       Impact factor: 5.992

9.  Biochemical profile of stone-forming patients with diabetes mellitus.

Authors:  Charles Y C Pak; Khashayar Sakhaee; Orson Moe; Glenn M Preminger; John R Poindexter; Roy D Peterson; Paul Pietrow; Wesley Ekeruo
Journal:  Urology       Date:  2003-03       Impact factor: 2.649

10.  Association of body mass index and urine pH in patients with urolithiasis.

Authors:  Wei-Ming Li; Yii-Her Chou; Ching-Chia Li; Chia-Chu Liu; Shu-Pin Huang; Wen-Jeng Wu; Chi-Wen Chen; Chien-Yu Su; Mei-Hui Lee; Yu-Ching Wei; Chun-Hsiung Huang
Journal:  Urol Res       Date:  2009-05-26
View more
  5 in total

1.  Osteogenic changes in kidneys of hyperoxaluric rats.

Authors:  Sunil Joshi; William L Clapp; Wei Wang; Saeed R Khan
Journal:  Biochim Biophys Acta       Date:  2015-06-27

Review 2.  Use of Ultrasound in Pediatric Renal Stone Diagnosis and Surgery.

Authors:  Jeffrey C Morrison; Trudy Kawal; Jason P Van Batavia; Arun K Srinivasan
Journal:  Curr Urol Rep       Date:  2017-03       Impact factor: 3.092

3.  Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden.

Authors:  Kirsten Kusumi; Brian Becknell; Andrew Schwaderer
Journal:  Pediatr Nephrol       Date:  2014-12-07       Impact factor: 3.714

4.  Estimating the nationwide, hospital based economic impact of pediatric urolithiasis.

Authors:  Hsin-Hsiao S Wang; John S Wiener; Michael E Lipkin; Charles D Scales; Sherry S Ross; Jonathan C Routh
Journal:  J Urol       Date:  2014-10-08       Impact factor: 7.450

5.  The evolving epidemiology of stone disease.

Authors:  Ksenia Roudakova; Manoj Monga
Journal:  Indian J Urol       Date:  2014-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.